This is a preview of subscription content, log in via an institution to check access.
Reference
Doan TN, et al. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study. Journal of Antimicrobial Chemotherapy : 5 Oct 2018. Available from: URL: http://doi.org/10.1093/jac/dky403
Rights and permissions
About this article
Cite this article
Rifapentine + isoniazid best option for latent TB. PharmacoEcon Outcomes News 814, 24 (2018). https://doi.org/10.1007/s40274-018-5367-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5367-3